IRLA logo

IRulya Therapeutics Inc.

IRLA
Healthcare|Biotechnology|US
$31.00
+1.69 (+5.77%)
Tangible Book / Share
$17.69
Cash / Share
$18.91
Next Earnings Report
Nov 11, 2026
EPS est. -$1.39
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Aug 5, 2026 (S-3/A). Possible dilution.

Upcoming Data Readouts (2)

Dec 2026
Est. completion
P2Bronchiolitis Obliterans Syndrome
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
NCT06018766n=30
Mar 2028
Est. completion
P2Pulmonary Hypertension Due to Lung Diseases and Hypoxia
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05798923n=85

Recent Press Releases

IRulya Therapeutics to Participate in the Craig-Hallum Biotech Catalyst Conference
Oct 15, 2026 · GlobeNewsWire
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
Oct 9, 2026 · GlobeNewsWire
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
Sep 17, 2026 · GlobeNewsWire
Quince Therapeutics to Participate in September 2026 Investor Conferences
Sep 3, 2026 · GlobeNewsWire
Quince Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Update
Aug 14, 2026 · GlobeNewsWire

SEC Filings (91)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 19, 20268-KMaterial eventDocumentIndex
Oct 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Oct 9, 20268-KMaterial eventDocumentIndex
Oct 8, 2026S-8Employee stock planDocumentIndex
Oct 6, 20268-KMaterial eventDocumentIndex
Oct 2, 2026DEFA14AProxy / shareholder voteDocumentIndex
Oct 2, 20268-KMaterial eventDocumentIndex
Sep 14, 20268-KMaterial eventDocumentIndex
Sep 4, 20268-KMaterial eventDocumentIndex
Aug 27, 20268-KMaterial eventDocumentIndex
Aug 25, 2026DEF 14AProxy / shareholder voteDocumentIndex
Aug 24, 2026EFFECTDocumentIndex
Aug 17, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 202610-QQuarterly reportDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 5, 2026S-3/AShelf registrationDocumentIndex
Aug 4, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jul 31, 20268-KMaterial eventDocumentIndex
Jul 31, 2026PRE 14AProxy / shareholder voteDocumentIndex
Jul 31, 2026S-3Shelf registrationDocumentIndex
Jul 30, 20268-K/AMaterial eventDocumentIndex
Jun 26, 20268-K/AMaterial eventDocumentIndex
Jun 26, 20268-KMaterial eventDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
Jun 11, 2026DDocumentIndex
Jun 11, 2026DDocumentIndex
Jun 10, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 21, 20268-KMaterial eventDocumentIndex
May 18, 20268-K/AMaterial eventDocumentIndex
May 18, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 11, 202610-QQuarterly reportDocumentIndex
Apr 28, 20268-KMaterial eventDocumentIndex
Apr 27, 2026ARSAnnual report to holdersDocumentIndex
Apr 27, 2026DEFA14AProxy / shareholder voteDocumentIndex